Genomic evaluation during permeability of indomethacin and its solid dispersion

Journal of Drug Targeting

Volumn 19, Issue 8, 2011, Pages 615-623

  Khan, Sheraz ^a   Elshaer, Amr ^a   Rahman, Ayesha S ^a   Hanson, Peter ^a   Perrie, Yvonne ^a   Mohammed, Afzal R ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Caco 2 cells; Indomethacin; Microarray; Permeability; Solid dispersion

Indexed keywords

ABC TRANSPORTER; CARRIER PROTEINS AND BINDING PROTEINS; INDOMETACIN; MACROGOL 8000; SOLUTE CARRIER TRANSPORTER PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; CHEMICAL INTERACTION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG ABSORPTION; DRUG FORMULATION; DRUG MIXTURE; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TRANSPORT; GENE EXPRESSION; GENETIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; SOLID DISPERSION; SPECTROPHOTOMETRY;

ABSORPTION; CACO-2 CELLS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG COMPOUNDING; GENE EXPRESSION; HUMANS; INDOMETHACIN; MICROARRAY ANALYSIS; MICROSCOPY, ELECTRON, SCANNING; P-GLYCOPROTEIN; PRINCIPAL COMPONENT ANALYSIS; SOLUBILITY; SPECTROPHOTOMETRY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 80051766851     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.531730     Document Type: Article

References (30)

1. Bakos E, Evers R, Sinkó E, Váradi A, Borst P, Sarkadi B. (2000). Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol Pharmacol, 57, 760-768. (Pubitemid 30183717)
2. Chen J, Zhu Y, Hu M. (1994). Mechanisms and kinetics of uptake and efux of l-methionine in an intestinal epithelial model (Caco-2). J Nutr, 124, 1907-1916. (Pubitemid 24334625)
3. Collnot EM, Baldes C, Wempe MF, Hyatt J, Navarro L, Edgar KJ, Schaefer UF, Lehr CM. (2006). Infuence of vitamin E TPGS poly(ethylene glycol) chain length on apical efux transporters in Caco-2 cell monolayers. J Control Release, 111, 35-40. (Pubitemid 43289992)
4. Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm, 278, 119-131. (Pubitemid 38670443)
5. Craig DQM, Newton JM. (1991). Characterisation of polyethylene glycols using diferential scanning calorimetry. Int J Pharm, 74, 33-41.
6. Crowther DJ. (2002). Applications of microarrays in the pharmaceutical industry. Curr Opin Pharmacol, 2, 551-554.
7. Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P, Van den Mooter G. (2000). Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci, 10, 311-322. (Pubitemid 30317467)
8. Dantzig AH, Bergin L. (1990). Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim Biophys Acta, 1027, 211-217. (Pubitemid 20279132)
9. Donnenberg VS, Donnenberg AD. (2005). Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol, 45, 872-877. (Pubitemid 41060226)
10. Dubois JL, Ford JL. (1985). Similarities in the release rates of diferent drugs from polyethylene glycol 6000 solid dispersions. J Pharm Pharmacol, 37, 494-495. (Pubitemid 15042945)
11. Eisen MB, Spellman PT, Brown PO, Botstein D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA, 95, 14863-14868. (Pubitemid 29003722)
12. Faassen F, Vogel G, Spanings H, Vromans H. (2003). Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm, 263, 113-122. (Pubitemid 37087938)
13. Getz G, Levine E, Domany E. (2000). Coupled two-way clustering analysis of gene microarray data. Proc Natl Acad Sci USA, 97, 12079-12084.
14. Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. (1995). Physicochemical characterization and dissolution of norfoxacin:cyclodextrin inclusion compounds and PEG solid dispersions. Int J Pharm, 123, 53-63.
15. Hilgers AR, Conradi RA, Burton PS. (1990). Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res, 7, 902-910. (Pubitemid 20349761)
16. Huang Y. (2007). Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy. Cancer Metastasis Rev, 26, 183-201. (Pubitemid 46452190)
17. Hugger ED, Audus KL, Borchardt RT. (2002). Efects of poly(ethylene glycol) on efux transporter activity in Caco-2 cell monolayers. J Pharm Sci, 91, 1980-1990. (Pubitemid 36254934)
18. Johnson BM, Charman WN, Porter CJ. (2002). An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efux and enterocyte-based metabolism in excised rat intestine. AAPS Pharm Sci, 4, 40.
19. Ling V, Tompson LH. (1974). Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol, 83, 103-116.
20. Molday RS. (2007). ATP-binding cassette transporter ABCA4: molecular properties and role in vision and macular degeneration. J Bioenerg Biomembr, 39, 507-517.
21. Mount DB, Mercado A, Song L, Xu J, George AL Jr, Delpire E, Gamba G. (1999). Cloning and characterization of KCC3 and KCC4, new members of the cation-chloride cotransporter gene family. J Biol Chem, 274, 16355-16362.
22. Rege BD, Kao JP, Polli JE. (2002). Efects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci, 16, 237-246.
23. Saeed A, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Tiagarajan M, White JA, Quackenbush J. (2006). TM4 microarray software suite. Methods Enzymol, 411, 134-193.
24. Schena M, Shalon D, Davis RW, Brown PO. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 270, 467-470.
25. Shen Q, Lin Y, Handa T, Doi M, Sugie M, Wakayama K, Okada N, Fujita T, Yamamoto A. (2006). Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies. Int J Pharm, 313, 49-56.
26. Stenberg P, Luthman K, Artursson P. (2000). Virtual screening of intestinal drug permeability. J Control Release, 65, 231-243. (Pubitemid 30122928)
27. Stouch TR, Gudmundsson O. (2002). Progress in understanding the structure-activity relationships of P-glycoprotein. Adv Drug Deliv Rev, 54, 315-328. (Pubitemid 34260956)
28. Taipalensuu J, Törnblom H, Lindberg G, Einarsson C, Sjöqvist F, Melhus H, Garberg P, Sjöström B, Lundgren B, Artursson P. (2001). Correlation of gene expression of ten drug efux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ter, 299, 164-170. (Pubitemid 32905131)
29. Tibshirani R, Hastie T, Eisen M, Ross D, Botstein D, Brown P. (1999). Clustering Methods for the Analysis of DNA Microarray Data. Technical Report. Department of Statistics, Stanford University, Stanford.
30. Yee S. (1997).In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm Res, 14, 763-766. (Pubitemid 27281671)